Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Crespo-Leiro, M. G.
Right arrow Articles by Cuenca-Castillo, J. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Crespo-Leiro, M. G.
Right arrow Articles by Cuenca-Castillo, J. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Surgical treatment of heart failure: heart transplantation and ventricular restoration surgery

Maria G. Crespo-Leiro* and Jose J. Cuenca-Castillo

Area del Corazón, Complejo Hospitalario Universitario Juan Canalejo, Xubias, 84, La Coruña, 15006, Spain

* Corresponding author. Tel: +34 981 178304; fax: +34 981 178299. E-mail address: mcrelei{at}canalejo.org

Heart transplantation (HT) is the only established surgical approach to the treatment of refractory heart failure. Survival after HT in Spain is 80% at 1 year, 70% at 5 years, and 60% at 10 years. The causes of death after HT depend on the time elapsed since transplant. In the first month, deaths are due mainly to acute allograft failure, between months 1 and 12 to infection and rejection, and thereafter to neoplasia, sudden cardiac arrest, or allograft vasculopathy. The main limitation on the application of HT to appropriately selected HF patients is the shortage of donors. Ventricular restoration surgery (VRS) comprises a set of surgical procedures for prevention of post-infarction ventricular remodelling. These techniques aim to reduce the volume and restoring the elliptical shape of the left ventricle by exclusion of the infarcted non-contracting segment. No randomized studies assessing the efficacy of VRS have yet been completed, and the results of the international multicentre trial STICH, in which patients with ischaemic cardiomyopathy are randomized to medical therapy, coronary bypass alone, or coronary bypass with VRS, are eagerly awaited. However, data from a large registry of patients with VRS show good results, with an overall 30-day mortality of 5.3% and a 5-year survival rate of 68%.

Key Words: Heart transplantation • Ventricular restoration surgery


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.